Impaired Endothelial Progenitor Cell Mobilization and Dysfunctional Bone Marrow Stroma in Diabetes MellitusPeter E. Westerweel, Marianne C. Verhaar|PLoS ONE|2013Cited by 67
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLLLina van der Straten, Mark‐David Levin, Ellen van der Spek et al.|Blood|2023Cited by 27
Detecting measurable residual disease beyond 10−4 by an IGHV leader-based NGS approach improves prognostic stratification in CLLPaul J. Hengeveld, Anton W. Langerak, Michèle Y. van der Klift et al.|Blood|2022Cited by 24
High-throughput Proteomics Identifies THEMIS2 as Independent Biomarker of Treatment-free Survival in Untreated CLLPaul J. Hengeveld, Anton W. Langerak, P. Martijn Kolijn et al.|HemaSphere|2023Cited by 5
High coincidence of chronic lymphocytic leukemia and myeloproliferative neoplasms: detection bias or a clue to a common pathophysiological path?Claire van de Ree–Pellikaan, Peter E. Westerweel, Lina van der Straten et al.|Leukemia & lymphoma/Leukemia and lymphoma|2016Cited by 2